Next, we sought to apply a pharmacological approach to target ARNT in neutrophils and determine its effects on neutrophil function and colorectal cancer development to test whether we can recapitulate our findings from genetically targeting ARNT. The gene discussed is ARNT; the disease is colorectal cancer.